Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2017
Source ID
10.1016/j.neuroimage.2017.05.058

Entities

People

  • Andy Horng
  • Anne Maass
  • Gil D. Rabinovici
  • Renaud La Joie
  • Samuel N Lockhart
  • Susan Landau
  • Suzanne L. Baker
  • William J. Jagust

Organizations

  • Alzheimer's Drug Discovery Foundation
  • Avid Radiopharmaceuticals
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eli Lilly and Company
  • Foundation for the National Institutes of Health
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson Pharmaceutical Research and Development
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense